NCT03448718 Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations Status COMPLETED Phase PHASE2
NCT03422276 Brain Injury Rehabilitation Improving the Transition Experience Status COMPLETED Phase NA
NCT03419325 A Genomic Approach for Clopidogrel in Caribbean Hispanics Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03417856 Defining the Skin and Blood Biomarkers of Ichthyosis Status ENROLLING_BY_INVITATION Phase N/A
NCT03403036 Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies Status COMPLETED Phase PHASE4
NCT03402139 Early Childhood Obesity Programming by Intrauterine Growth Restriction Status RECRUITING Phase N/A
NCT03369730 Reducing the Duration of Untreated Psychosis in the United States Status COMPLETED Phase N/A
NCT03359356 Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT03349034 Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps Status COMPLETED Phase PHASE2
NCT03348683 Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients Status COMPLETED Phase PHASE2
NCT03341806 Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma Status COMPLETED Phase PHASE1